Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Maria Luigia Vigliotti"'
Autor:
Christina Cox, Michele Spina, Samantha Ferrari, Luigi Rigacci, Francesco Merli, Francesco Angrilli, Silvia Bolis, Antonino Mulè, Stefano Luminari, Maria Luigia Vigliotti, Ombretta Annibali, Pier Luigi Zinzani, Samantha Pozzi, Guido Gini, Elisabetta Bonifacio, Francesca Pregnolato, Serena Broggi, S. Kovalchuk, Scalzulli Rp, Angela Maria Mamusa, Armando Santoro, Gloria Margiotta-Casaluci, L. Flenghi, Umberto Vitolo, Fondazione Italiana Linfomi
Publikováno v:
Hematological Oncology
Doxorubicin is the most effective single agent in the treatment of non‐Hodgkin's lymphoma (NHL). Its use is limited because of the cardiac toxicity primarily in elderly patients (pts) and in pts with history of cardiac disease. Liposomal doxorubici
Autor:
Silvia Bolis, Ombretta Annibali, Stefano Luminari, Scalzulli Rp, Antonino Mulè, Francesco Angrilli, Luigi Rigacci, Christina Cox, Umberto Vitolo, L. Flenghi, Francesca Pregnolato, Samantha Pozzi, Armando Santoro, Serena Broggi, Gloria Margiotta-Casaluci, Maria Luigia Vigliotti, Angela Maria Mamusa, S. Kovalchuk, G. Gini, Samantha Ferrari, Pier Luigi Zinzani, Elisabetta Bonifacio, Francesco Merli, Michele Spina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::871492e56ebc3b3d04e9eeaecde37fac
https://doi.org/10.1002/hon.2764/v2/response1
https://doi.org/10.1002/hon.2764/v2/response1
Autor:
G. Farina, A. Camera, S. Iaccarino, E. Attingenti, F. Frigeri, M. Iovine, Maria Luigia Vigliotti, M. Troiano
Publikováno v:
Hematological Oncology. 37:441-442
Autor:
Pellegrino Musto, Luca Laurenti, Angela Padula, Vittorio Simeon, Michele Gilio, Giovanni D'Arena, Marco Tucci, Giovanni Di Minno, Giacomo Loseto, Francesco Silvestris, Fiorella D'Auria, Sonya De Lorenzo, Anna Passarelli, Idanna Innocenti, Vincenzo De Feo, Matteo Nicola Dario Di Minno, Michele Cimminiello, Maria Luigia Vigliotti
Rituximab is an effective treatment for CD20 + B-cell malignancies and autoimmune disorders. However, adverse drug reactions (ADRs) may occur after rituximab infusion, causing, in rare cases, its discontinuation. In this multicenter, retrospective st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20231e3ccdbb88be275aba2f0159731e
http://hdl.handle.net/10807/117527
http://hdl.handle.net/10807/117527
Autor:
Benedetta Puccini, Alessandro Broccoli, Emanuela Merla, Pier Luigi Zinzani, Attilio Guarini, Alberto Fabbri, Michele Baccarani, Beatrice Casadei, Vittorio Stefoni, Lisa Argnani, Federica Quirini, Vincenzo Pavone, Filippo Ballerini, Gerlando Quintini, Maria Luigia Vigliotti, Letizia Gandolfi, Cinzia Pellegrini, Enrico Derenzini
Publikováno v:
Hematological Oncology. 31:179-182
Current treatments for non-Hodgkin lymphomas are not optimally effective. Among new agents, bortezomib seems to play a pivotal role in the regulation of several cell pathways involved in the development of lymphomas. After results were obtained with
Autor:
Nicola Di Renzo, Giovanni Quarta, Giuseppe Polimeno, Ugo Consoli, Raimondo Ferrara, Santo Neri, Stefano Sacchi, Pellegrino Musto, Raffaella Marcheselli, Enrico Balleari, Luciano Masini, Alessandro Pastorini, Antonio Lazzaro, Gabriele Buda, Alberto Fragasso, Maria Luigia Vigliotti, Alessandra Zoboli, Fortunato Morabito
Publikováno v:
Leukemia & Lymphoma. 52:1942-1948
Several trials comparing the efficacy of standard melphalan and prednisone (MP) therapy with MP plus thalidomide (MPT) in elderly patients with multiple myeloma (MM) have been reported, with inconsistent results. The primary goal of our study was to
Autor:
Nicola Cascavilla, Saverio Mantuano, Lucia Mastrullo, Giovanni D'Arena, Antonio Abbadessa, Maria Rosaria Villa, Matteo Dell’Olio, Antonio La Sala, Maria Luigia Vigliotti, Potito Rosario Scalzulli
Publikováno v:
European Journal of Haematology. 82:235-239
We report four patients (mean age 65 yr; range 40-77 yr) affected by acquired pure red cell aplasia (PRCA) complicating chronic lymphoid disorders and treated with anti-CD20 monoclonal antibody rituximab. Three out of four patients were given packed
Publikováno v:
Leukemia & Lymphoma. 46:1321-1327
Primary breast lymphomas (PBL) are uncommon neoplasms. Seven PBL were diagnosed between March 1993 and October 2002. A lumpectomy (n = 4) or radical mastectomy (n = 3) was performed; 5 patients were in clinical stage (CS)II and 2 in CS IV; 6 patients
Autor:
Maura Brugiatelli, Giovanni D'Arena, Maria Luigia Vigliotti, Nicola Di Renzo, Michael J. Keating
Publikováno v:
Leukemia & Lymphoma. 44:223-228
B-cell chronic lymphoproliferative disorders have been recognized as a heterogeneous group of neoplastic diseases affecting the lymphoid system. They are frequently characterized by leukemic manifestations with peripheral blood and/or bone marrow inv
Autor:
Giampiero Romano, Giuseppe Mele, Nicola Di Renzo, Angelo Michele Carella, Clelia Musto, Antonio La Sala, Maria Luigia Vigliotti, Matteo Dell’Olio, Alfredo Tartarone
Publikováno v:
The Hematology Journal. 5:453-455